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based nutritional interventions are applied at 90% coverage, only a
20% reduction in stunting would be achieved (Bhutta et al., 2013).
To realize the United Nations' Sustainable Development Goal #2 and
the World Health Assembly's target of 40% reduction in the number of
stunted children under ﬁve years of age by 2025 (Weise, 2012), it is
crucial to understand the pathogenesis of stunting. Human growthStunting is a complex health challenge, the causative mechanisms
for which are still poorly understood. Despite concerted efforts at im-
proving childhood nutritional and health status during the Millennium
Development Goal era, the reduction in stunting in Africa particularly
was a modest 10–15% with a wide variation across different countries.
As such, stunting remains an intractable problem that continues to af-
fect one-quarter of the world's young children. Stunted children have
a higher risk of mortality— stunting is responsible for 14% of childhood
deaths, decreased motor and cognitive function as well as behavioral
abnormalities, and impaired immunity (Weise, 2012). Long-term
health consequences include shorter adult height (Victora et al.,
2008), less schooling (Weise, 2012), reduced physical work capacity
and low wages in adulthood (de Onis et al., 2012), increased risk of
high body fat/obesity and cardiovascular disease (Victora et al., 2008),
and poor perinatal outcomes in offspring born to stunted mothers
(Victora et al., 2008).
It is currently understood that the main causes of stunting begin in
utero and manifest by age 2–3 years, and include intrauterine growth
retardation and undernutrition, often in combination with frequent
infections such as diarrhea (Weise, 2012). Other predictors of stunting
include suboptimal breastfeeding and complementary feeding prac-
tices, low birth weight, child neglect or negative parent/child interac-
tions, and lower maternal education (Weise, 2012). Nutritional
supplementation interventions to reduce stunting have had mixed re-
sults. Iron with folic acid during pregnancy (Nisar et al., 2016) and
iron alone among children (Chwang et al., 1988), were beneﬁcial for im-
proving stunting; however, iron alone or with zinc during infancy hadm.2016.02.030.
nal Sciences, Cornell University,
. This is an open access article underno effect on growth (Dijkhuizen et al., 2001). Even if ten evidence-
is regulated by the mechanistic target of rapamycin complex C1
(mTORC1), a pathway that is mediated by the availability of amino
acids (Semba et al., 2016). As the amino acid requirements of young
children—particularly those at high risk of stunting—are not established,
and advances in metabolomics and mass spectrometry facilitate the
rapid quantiﬁcation of serum metabolites including amino acids, it is
timely to investigate their role in the pathogenesis of stunting.
The prevalence of stunting is highest in Africa at 40% overall, with
few signs of improvement among these 64 million children since 2010
(de Onis et al., 2012). Malawi has one of the highest rates of stunting,
with a prevalence of 48% and 41% in rural and urban areas, respectively
(USAID, 2014). In the cross-sectional study by Semba et al., published in
this issue of EBioMedicine, 62% (N= 313 children aged 12–59 months)
were stunted in six rural villages of southern Malawi (Semba et al.,
2016). Using a targeted metabolomics approach to measure amino
acids, glycerophospholipids, sphingolipids, and other metabolites, the
authors found that amino acid concentrations were associated with
stunting. All nine essential amino acids were signiﬁcantly lower in the
stunted children compared to controls (HAZ N −2). Additionally,
stunted children had signiﬁcantly lower serum concentrations of
conditionally essential amino acids (arginine, glycine, and glutamine),
non-essential amino acids (asparagine, glutamate, and serine) and
six sphingolipids, as well as altered serum glycerophospholipid
concentrations.
Author-identiﬁed strengths of the current study include the use of
LC–MS/MS methodology for quantiﬁcation of serum metabolites, the
community-based sample in rural Africa where stunting is prevalent,
and a validated platform for quantiﬁcation of serummetabolites. Addi-
tional strengths include the large sample size, and exclusion of children
with diarrhea to lessen infection-related confounding factors. Themajor
limitation is that it is a cross-sectional study and the possibility of re-
verse causation warrants some caution in interpretation of the results
as another metabolic abnormality may cause stunting that in turn canthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ple, a recent report indicated that undernutrition can increase the pro-
teolytic activity of the gutmicrobiome (Mayneris-Perxachs et al., 2016).
Semba et al.'s study provides support for larger longitudinal pro-
spective studies to better understand the correlation between amino
acids and stunting before initiating randomized controlled trials to fur-
ther explore the potential causality of this association (Semba et al.,
2016). Additionally, future studies regarding other potential mediators
of stunting, such as vitamin D and the taxonomic and functional gene
expression of the gut microbiome, must be undertaken to completely
capture the causes of stunting. It iswell established that vitamin Dmod-
ulates immunity in addition to its role in bone homeostasis, which is
also regulated by mTORC1. Several essential amino acids, including
tryptophan and threonine, are involved in gastrointestinal function by
acting as precursors for critical neurotransmitters such as serotonin or
components of the mucus layer in the gut (respectively) (Semba et al.,
2016). Low amino acid levels and their subsequent effect on linear
growth metabolism including mTORC1 depression may have repercus-
sions on the current recommendations for micronutrient and lipid
supplementation that are found to be less effective than predicted.
Additionally, as Semba et al. note, this study gives support to the nega-
tive impact of protein malnutrition on growth, which has been de-
emphasized since the 1970s in favor of addressing micronutrient deﬁ-
ciencies. Elucidating the mechanistic pathways that lead to stunting
through application of advances in modern technology — and this
study is an important step in that direction— are critical for its preven-
tion to improve immediate and long-termhealth formillions of children
around the world.
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